AA 是一种罕见的胃肠道癌症，发病率低，每 10 万人中约有 1.3 人发病，且属于罕见病范畴，目前尚无 FDA 批准的特效疗法。标准治疗方案为细胞减灭术联合腹腔热灌注化疗（CRS + HIPEC），但并非所有患者都适合手术。传统观念认为 AA 对全身化疗反应不佳，不过近年来，靶向治疗、免疫治疗和腹腔内定向治疗展现出一定潜力。

Patients with appendiceal adenocarcinoma face increased risk of secondary cancers, including colorectal, within 10 years, per ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

Rate of gene fusion/rearrangement identification in GI cancers as sequencing evolved from limited panels to whole exome sequencing. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

A systematic review and meta-analysis on evaluating the efficacy and safety of netupitant/palonosetron compared to aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients ...